Clinical Trials and Research
Clinical Trails
You may benefit from standard radiation oncology and chemotherapy protocols that improve the outcome of your particular cancer and symptoms. Or you may qualify for one of our extensive clinical trials – research studies that are designed to find better treatments for cancer patients based on the most up-to-date information from around the country.
As a founding member of the Dana Farber/Harvard Cancer Center (DF/HCC), Beth Israel Deaconess is part of the largest cancer research consortium in the country, with access to a broad array of the most current clinical trials. The BIDMC Cancer Clinical Trials Office coordinates trials in connection with DF/HCC and the Eastern Cooperative Oncology Group (ECOG), among others.
Learn more about available clinical trials >>
Research
Each year, numerous contributions of BIDMC research faculty are:
- Awarded prominent and highly competitive research grants
- Recognized for far-ranging scientific achievement
- Engaged in clinical trials, to bring research from the laboratory bench to the patient bedside
- Published in prestigious scientific and medical journals
Research into individually tailored treatments is a key focus of The Cancer Centerat BIDMC. Physician researchers are working to understand the basic science of various brain diseases to predict how they will respond to different therapies, such as chemotherapy and radiation, and then tailoring each patient’s care accordingly.
